Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if MDGL is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
70 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 33 days ago
Red flags: 1
415 filers reported a long position in MDGL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | $1.2B | 2.1M | +0.1% |
| RTW INVESTMENTS, LP | $1.1B | 2M | Unchanged |
| Jupiter Topco LLC | $1B | 1.9M | — |
| Avoro Capital Advisors LLC | $984.4M | 1.8M | +0.8% |
| PAULSON & CO. INC. | $719.5M | 1.3M | -3.7% |
| BlackRock, Inc. | $644.8M | 1.2M | -23% |
| VANGUARD CAPITAL MANAGEMENT LLC | $448.7M | 835.7K | +1% |
| WELLINGTON MANAGEMENT GROUP LLP | $443.4M | 825.7K | +18.8% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $419.8M | 781.7K | -7.1% |
| STATE STREET CORP | $283M | 527.1K | -13.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.